Holding(s) in Company
Summary by AI BETAClose X
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
JE00BLKGSR75
Issuer Name
INTEGRATED DIAGNOSTICS HOLDINGS PLC
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Actis LLP
City of registered office (if applicable)
London
Country of registered office (if applicable)
UK
4. Details of the shareholder
|
Name |
City of registered office |
Country of registered office |
|
Actis IDH Limited |
Saint Peter Port |
Guernsey |
5. Date on which the threshold was crossed or reached
31-Mar-2026
6. Date on which Issuer notified
08-Apr-2026
7. Total positions of person(s) subject to the notification obligation
|
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|
|
Resulting situation on the date on which threshold was crossed or reached |
0.000000 |
0.000000 |
0.000000 |
0 |
|
Position of previous notification (if applicable) |
|
|
|
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
|
Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
|
GB00B65TLW28 |
0 |
0 |
0.000000 |
000 |
|
Sub Total 8.A |
0 |
0% |
||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
|
|
Sub Total 8.B1 |
|
|
|
|
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
|
|
|
|
|
|
|
|
Sub Total 8.B2 |
|
|
|
||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
|
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
Actis LLP (chain 1) |
Actis GP LLP (as general partner of Actis Global 4 LP) |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 1) |
Actis Global 4 LP |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 1) |
Global 4 Sellco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 1) |
IDH Issuerco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 1) |
Actis IDH Limited (entity being disposed of) |
21.670000 |
0.000000 |
21.670000% |
|
Actis LLP (chain 2) |
Actis GP LLP (as general partner of Actis Global 4A LP) |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 2) |
Actis Global 4A LP |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 2) |
Global 4 Sellco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 2) |
IDH Issuerco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 2) |
Actis IDH Limited (entity being disposed of) |
21.670000 |
0.000000 |
21.670000% |
|
Actis LLP (chain 3) |
Actis GP LLP (as general partner of Actis Global 4C LP) |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 3) |
Actis Global 4C LP |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 3) |
Global 4 Sellco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 3) |
IDH Issuerco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 3) |
Actis IDH Limited |
21.670000 |
0.000000 |
21.670000% |
|
Actis LLP (chain 4) |
Actis Guernsey GP Limited (as General partner of Actis 4 Co-Investment Scheme LP) |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 4) |
Actis 4 Co-Investment Scheme LP |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 4) |
Global 4 Sellco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 4) |
IDH Issuerco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 4) |
Actis IDH Limited (entity being disposed of) |
21.670000 |
0.000000 |
21.670000% |
|
Actis LLP (chain 5) |
Actis GP LLP (as general partner of Actis Africa 4 LP) |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 5) |
Actis Africa 4 LP |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 5) |
Africa 4 Sellco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 5) |
IDH Issuerco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 5) |
Actis IDH Limited (entity being disposed of) |
21.670000 |
0.000000 |
21.670000% |
|
Actis LLP (chain 6) |
Actis GP LLP (as general partner of Actis Africa 4A LP) |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 6) |
Actis Africa 4A LP |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 6) |
Africa 4 Sellco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 6) |
IDH Issuerco Limited |
0.000000 |
0.000000 |
0.000000% |
|
Actis LLP (chain 6) |
Actis IDH Limited |
21.670000 |
0.000000 |
21.670000% |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
As announced on 13 November 2025 by Integrated Diagnostics Holdings plc (the "Company"), Actis GP LLP and Actis Guernsey GP Limited, each a subsidiary of Actis LLP and which through funds under their management control shares representing 21.67% of the Company (the "Actis Shareholding"), have agreed to dispose, by way of an indirect share sale of Actis IDH Limited, of the entire Actis Shareholding to a special purpose vehicle, the majority of which is controlled by funds managed by Elliott Investment Management L.P. (the "Transaction"). The Transaction, which at the time of the announcement was conditional on the receipt of regulatory clearance (which was received on 31 March 2026, at which point the transfer became unconditional), will settle on Thursday 9 April 2026.
12. Date of Completion
08-Apr-2026
13. Place Of Completion
London, United Kingdom
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 12 hours ago Johnson Matthey
- 13 hours ago Galliford Try
- 13 hours ago Galliford Try
- 13 hours ago Centrica
- 14 hours ago Smith & Nephew